Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Cancer Drug Targets
|
January 4, 2025
Beyond CTLA-4 and PD-1: Novel Insights into MAO-A as a Next- Generation Immune Checkpoint Modulator for Cancer Immunotherapy
Prajna Maity, Debjeet Sur
Endocrine, Metabolic & Immune Disorders Drug Targets
|
July 5, 2022
Role of Macrophage in Type 2 Diabetes Mellitus: Macrophage Polarization a New Paradigm for Treatment of Type 2 Diabetes Mellitus
Sarmin Banu, Debjeet Sur
Journal of Basic and Clinical Physiology and Pharmacology
|
February 11, 2024
Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat
Oishani Chatterjee, Debjeet Sur
Liver Research (Beijing, China)
|
April 13, 2026
Autophagy-mediated Kupffer cell polarization in liver cirrhosis reversal: Mechanistic insights and therapeutic strategies
Debjeet Sur, Gargi Banik
Current Rheumatology Reviews
|
March 21, 2025
The TIM-3/Gal-9 Pathway: A Promising Therapeutic Target for Regulation of Immune Checkpoint in Rheumatoid Arthritis
Debjeet Sur, Riya Pramanik
European Journal of Pharmacology
|
August 23, 2023
Artificially induced in situ macrophage polarization: An emerging cellular therapy for immuno-inflammatory diseases
Oishani Chaterjee, Debjeet Sur
Drug Development Research
|
March 29, 2026
Blueprint for Drug Repurposing Success: Foundational Concepts and Practical Framework
Aayusree Ray, Shreya Dey, Debjeet Sur
Immunopharmacology and Immunotoxicology
|
March 13, 2024
Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis
Sourav Mondal, Sarthak Saha, Debjeet Sur
ACS Pharmacology & Translational Science
|
May 15, 2025
The 3C (Cell Culture, Computer Simulation, Clinical Trial) Solution for Optimizing the 3R (Replace, Reduction, Refine) Framework during Preclinical Research Involving Laboratory Animals
Susmita Roy, Mehnaz Parveen, Asis Bala, et al.
Protein and Peptide Letters
|
January 16, 2026
mRNA-Based Cancer Vaccines: A Review of the Current Scenario and Future Prospects
Sanchari Bhattacharya, Nilufa Easmin, Atanu Panja, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Cancer Drug Targets
|
January 4, 2025
Beyond CTLA-4 and PD-1: Novel Insights into MAO-A as a Next- Generation Immune Checkpoint Modulator for Cancer Immunotherapy
Prajna Maity, Debjeet Sur
Endocrine, Metabolic & Immune Disorders Drug Targets
|
July 5, 2022
Role of Macrophage in Type 2 Diabetes Mellitus: Macrophage Polarization a New Paradigm for Treatment of Type 2 Diabetes Mellitus
Sarmin Banu, Debjeet Sur
Journal of Basic and Clinical Physiology and Pharmacology
|
February 11, 2024
Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat
Oishani Chatterjee, Debjeet Sur
Liver Research (Beijing, China)
|
April 13, 2026
Autophagy-mediated Kupffer cell polarization in liver cirrhosis reversal: Mechanistic insights and therapeutic strategies
Debjeet Sur, Gargi Banik
Current Rheumatology Reviews
|
March 21, 2025
The TIM-3/Gal-9 Pathway: A Promising Therapeutic Target for Regulation of Immune Checkpoint in Rheumatoid Arthritis
Debjeet Sur, Riya Pramanik
European Journal of Pharmacology
|
August 23, 2023
Artificially induced in situ macrophage polarization: An emerging cellular therapy for immuno-inflammatory diseases
Oishani Chaterjee, Debjeet Sur
Drug Development Research
|
March 29, 2026
Blueprint for Drug Repurposing Success: Foundational Concepts and Practical Framework
Aayusree Ray, Shreya Dey, Debjeet Sur
Immunopharmacology and Immunotoxicology
|
March 13, 2024
Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis
Sourav Mondal, Sarthak Saha, Debjeet Sur
ACS Pharmacology & Translational Science
|
May 15, 2025
The 3C (Cell Culture, Computer Simulation, Clinical Trial) Solution for Optimizing the 3R (Replace, Reduction, Refine) Framework during Preclinical Research Involving Laboratory Animals
Susmita Roy, Mehnaz Parveen, Asis Bala, et al.
Protein and Peptide Letters
|
January 16, 2026
mRNA-Based Cancer Vaccines: A Review of the Current Scenario and Future Prospects
Sanchari Bhattacharya, Nilufa Easmin, Atanu Panja, et al.
Page
of 2